Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Rithm Capital Corp NRZ


Primary Symbol: RITM Alternate Symbol(s):  RITM.P.B

Real Estate
Rithm Capital Corp. is a global asset manager focused on real estate, credit and financial services. The Company’s investments in real estate related assets include its equity interest in operating companies, including origination and servicing platforms held through wholly owned subsidiaries, Newrez LLC (Newrez) and Genesis Capital LLC (Genesis), as well as investments in single-family rental (SFR), title, appraisal and property preservation and maintenance businesses. Its segments include Origination and Servicing, Investment Portfolio, Mortgage Loans Receivable, Asset Management and Corporate. The Investment Portfolio consists of mortgage servicing rights (MSR) related investments, real estate securities, properties and residential mortgage loans, consumer loans and certain ancillary investments and equity method investments. It operates its asset management business primarily through its wholly owned subsidiary, Sculptor Capital Management, Inc. (Sculptor).


NYSE:RITM - Post by User

Rithm Capital Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Eevhieon Jun 03, 2022 4:13am
113 Views
Post# 34728684

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance


FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.


 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities